|
2025-06-06 |
2025-06-05 |
S
Sale
|
KNOBELMAN DEBORAH
President & Interim CEO
Officer
|
24,838
-15.1%
0.87
USD 21,554
|
24,838
-15.1%
|
0.87
|
USD 21,554
|
|
|
2024-07-01 |
2024-06-28 |
B
Purchase
|
BISCHOFBERGER NORBERT W
PRESIDENT & CEO
Executive Director
|
204,670
+1.9%
1.25
USD 254,957
|
204,670
+1.9%
|
1.25
|
USD 254,957
|
|
|
2024-07-01 |
2024-06-27 |
B
Purchase
|
BISCHOFBERGER NORBERT W
PRESIDENT & CEO
Executive Director
|
410,848
+4.0%
1.17
USD 478,843
|
410,848
+4.0%
|
1.17
|
USD 478,843
|
|
|
2024-06-12 |
2024-06-12 |
B
Purchase
|
BISCHOFBERGER NORBERT W
PRESIDENT & CEO
Executive Director
|
881,913
+13.6%
1.24
USD 1,096,041
|
881,913
+13.6%
|
1.24
|
USD 1,096,041
|
|
|
2024-06-12 |
2024-06-11 |
B
Purchase
|
BISCHOFBERGER NORBERT W
PRESIDENT & CEO
Executive Director
|
744,308
+12.9%
1.09
USD 814,571
|
744,308
+12.9%
|
1.09
|
USD 814,571
|
|
|
2024-06-12 |
2024-06-10 |
B
Purchase
|
BISCHOFBERGER NORBERT W
PRESIDENT & CEO
Executive Director
|
1,378,901
+31.6%
0.88
USD 1,208,469
|
1,378,901
+31.6%
|
0.88
|
USD 1,208,469
|
|
|
2024-02-23 |
2024-02-21 |
S
Sale
|
Olek Elizabeth A
SR VP, CLINICAL SCIENCE
Officer
|
7,368
-3.7%
1.05
USD 7,765
|
7,368
-3.7%
|
1.05
|
USD 7,765
|
|
|
2024-02-23 |
2024-02-21 |
S
Sale
|
Frisbee Allison
SR VP, CORP OPERATIONS & LEGAL
Officer
|
12,105
-5.6%
1.05
USD 12,757
|
12,105
-5.6%
|
1.05
|
USD 12,757
|
|
|
2024-02-23 |
2024-02-21 |
S
Sale
|
Lin Charles Y
SR VP, RESEARCH & DEVELOPMENT
Officer
|
12,036
-4.9%
1.05
USD 12,685
|
12,036
-4.9%
|
1.05
|
USD 12,685
|
|
|
2024-01-05 |
2024-01-04 |
S
Sale
|
Dinsmore Christopher
Chief Scientific Officer
Officer
|
7,366
-2.7%
1.18
USD 8,718
|
7,366
-2.7%
|
1.18
|
USD 8,718
|
|
|
2024-01-05 |
2024-01-04 |
S
Sale
|
DiMartino Jorge
Chief Medical Officer & VP
Officer
|
12,009
-3.7%
1.18
USD 14,214
|
12,009
-3.7%
|
1.18
|
USD 14,214
|
|
|
2024-01-05 |
2024-01-04 |
S
Sale
|
Kosacz Barbara
COO & General Counsel
Officer
|
10,676
-1.1%
1.18
USD 12,636
|
10,676
-1.1%
|
1.18
|
USD 12,636
|
|
|
2023-12-13 |
2023-12-12 |
S
Sale
|
Dinsmore Christopher
Chief Scientific Officer
Officer
|
10,032
-3.6%
1.31
USD 13,092
|
10,032
-3.6%
|
1.31
|
USD 13,092
|
|
|
2023-12-13 |
2023-12-12 |
S
Sale
|
DiMartino Jorge
Chief Medical Officer & VP
Officer
|
17,367
-5.0%
1.31
USD 22,664
|
17,367
-5.0%
|
1.31
|
USD 22,664
|
|
|
2023-11-17 |
2023-11-17 |
B
Purchase
|
BISCHOFBERGER NORBERT W
President & CEO
Executive Director
|
97,935
+4.0%
1.08
USD 106,162
|
97,935
+4.0%
|
1.08
|
USD 106,162
|
|
|
2023-11-17 |
2023-11-16 |
B
Purchase
|
BISCHOFBERGER NORBERT W
President & CEO
Executive Director
|
262,433
+12.0%
1.00
USD 261,514
|
262,433
+12.0%
|
1.00
|
USD 261,514
|
|
|
2023-11-17 |
2023-11-15 |
B
Purchase
|
BISCHOFBERGER NORBERT W
President & CEO
Executive Director
|
1,370,688
+169.3%
0.80
USD 1,102,718
|
1,370,688
+169.3%
|
0.80
|
USD 1,102,718
|
|
|
2023-07-07 |
2023-07-06 |
S
Sale
|
Dinsmore Christopher
Chief Scientific Officer
Officer
|
6,634
-2.3%
1.75
USD 11,625
|
6,634
-2.3%
|
1.75
|
USD 11,625
|
|
|
2023-07-07 |
2023-07-06 |
S
Sale
|
Al-Wakeel Yasir B.
Chief Financial Officer
Officer
|
9,617
-2.7%
1.75
USD 16,852
|
9,617
-2.7%
|
1.75
|
USD 16,852
|
|
|
2023-07-07 |
2023-07-06 |
S
Sale
|
DiMartino Jorge
Chief Medical Officer & VP
Officer
|
10,818
-3.0%
1.75
USD 18,956
|
10,818
-3.0%
|
1.75
|
USD 18,956
|
|
